Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery.
This review offers a framework for prioritizing organoid applications in PD research and translation by distinguishing established findings from emerging technologies and providing a realistic assessment of current limitations.